Page 546 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 546

19  The Breast  531


                 (b)  Medullary	carcinoma
                     (i)  Though germline BRCA1 mutations are not present in most of these, hyper-
                       methylation  of  the  BRCA1  promoter  leading  to  downregulation  of  BRCA1
                       expression is noted in 67% tumours.
                    (ii)  They  presents  as  well-circumscribed,  soft,  fleshy  masses  (medulla  in  Latin
                       means marrow), which may be confused with benign lesions.
                     (iii)  Histopathology shows:
                       -	 A solid syncytial arrangement occupying more than 75% of the tumour,
                         with  the  tumour  cells  being  large,  pleomorphic,  having  vesicular  nuclei
                         with prominent nucleoli with frequent mitoses
                       -	 Lymphoplasmacytic infiltrate surrounding and within the tumour nests
                       -	 Pushing and noninfiltrative tumour margins
                       -	 Minimal or absent DCIS
                       -	 Absence  of  lymphatic  or  vascular  invasion.  Lymph  node  involvement
                         is rare.
                       -	 A better prognosis than NST.
                   The current WHO classification recommends medullary carcinomas and carcino-
                     mas with similar features into a group termed ‘carcinomas with medullary fea-
                     tures’.
                 (c)  Mucinous	(colloid)	carcinoma
                     (i)  Commonly presents as a circumscribed mass in older women and progresses
                       slowly
                    (ii)  Soft  in  consistency  with  a  pale  grey-blue  gelatinous  appearance  (due  to
                       mucin)
                     (iii)  Histopathology shows large pools of mucin, scattered within which are small
                       clusters of malignant cells.
                  (d)  Tubular	carcinoma
                     (i)  Incidence  of  this  tumour  has  increased  after  initiation  of  mammographic
                       screening.
                    (ii)  Affects women in their late forties.
                     (iii)  Tumours are frequently multifocal and bilateral.
                    (iv)  Histopathology shows well-formed tubules lined by malignant cells. There is
                       absence of myoepithelial cells. Tubular pattern should be seen in more than
                       75% of the tumour.
                    (v)  Apocrine snouts are present and calcification is common.
                    (vi)  Axillary metastasis is seen in fewer than 10% of the cases (excellent prognosis).
                 (e)  Invasive	papillary	carcinomas
                     (i)  A rare invasive carcinoma with papillary architecture.
                    (ii)  Clinical presentation is similar to NST but prognosis is better.
                	(f )	 Metaplastic	carcinoma
                     (i)  Represents a group of invasive breast cancers showing differentiation of the
                       tumour cells into squamous and mesenchymal elements (spindle, chondroid,
                       osseous and rhabdomyoid cells) which are mixed with carcinoma of usual
                       type.
                    (ii)  Based  on  nuclear  features,  metaplastic  carcinomas  are  classified  into
                       ‘low-grade tumours’ (eg, low-grade adenosquamous carcinoma or low-grade
                       spindle cell carcinoma), or ‘high-grade tumours’ (eg, high-grade squamous
                       cell carcinoma, or high-grade spindle cell carcinoma).
                     (iii)  They are triple-negative tumours, but have a worse prognosis than other forms
                       of triple-negative breast cancers.


             Prognostic or Predictive Factors of Carcinoma Breast
             Major	prognostic	factors
             •	 Lymph	 node	 metastases:  Axillary  lymph  node  status  is  the  single  most  important
               prognostic factor. With no involvement, 10-year disease-free survival rate is 70–80%,
               with 1–3 positive nodes; it is 35–40%, with more than 10 positive nodes, it is 10–15%.




                                  mebooksfree.com
   541   542   543   544   545   546   547   548   549   550   551